Is there a need to further subclassify pT2 renal cell cancers as implemented by the revised 7th TNM version?

European Urology

Volumn 59, Issue 2, 2011, Pages 258-263

  Waalkes, Sandra ^a   Becker, Frank ^b   Schrader, Andres J ^c,d   Janssen, Martin ^b   Wegener, Gerd ^a   Merseburger, Axel S ^a   Schrader, Mark ^c   Hofmann, Rainer ^d   Stöckle, Michael ^b   Kuczyk, Markus A ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF ULM MEDICAL SCHOOL   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Prognosis; Renal cell cancer; Survival; TNM 2010

Indexed keywords

PEPTIDE TRANSPORTER 2;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FISHER EXACT TEST; GERMANY; HUMAN; KAPLAN MEIER METHOD; KIDNEY CANCER; KIDNEY CELL; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; NEPHRON SPARING SURGERY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STUDENT T TEST; TUMOR VOLUME;

AGED; CARCINOMA, RENAL CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 78650713558     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2010.10.005     Document Type: Article

References (16)

1. P. Hermanek, D.E. Henson, R.V.P. Hutter, L.H. Sobin, TNM supplement. A commentary on uniform use 1993 Springer Berlin, Germany
2. F.L. Greene, D.L. Page, I.D. Fleming, A. Fritz, C.M. Balch, AJCC cancer staging manual ed 6. 2002 Springer New York, NY
3. L.H. Sobin, P. Hermanek, TNM classification of malignant tumours ed 4. 1987 Springer Berlin, Germany
4. L.H. Sobin, C. Wittekind, TNM classification of malignant tumours ed 5. 1997 Wiley-Liss New York, NY
5. G. Novara, V. Ficarra, and A. Antonelli Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol 58 2010 588 595
6. I. Frank, M.L. Blute, and B.C. Leibovich pT2 classification for renal cell carcinoma. Can its accuracy be improved? J Urol 173 2005 380 384
7. H. Moch, T. Gasser, M.B. Amin, J. Torhorst, G. Sauter, and M.J. Mihatsch Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors Cancer 89 2000 604 614
8. M.T. Gettman, M.L. Blute, B. Spotts, S.C. Bryant, and H. Zincke Pathologic staging of renal cell carcinoma: significance of tumor classification with the 1997 TNM staging system Cancer 91 2001 354 361
9. K.S. Hafez, A.F. Fergany, and A.C. Novick Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging J Urol 162 1999 1930 1933
10. T. Kinouchi, S. Saiki, and N. Meguro Impact of tumor size on the clinical outcomes of patients with Robson State I renal cell carcinoma Cancer 85 1999 689 695 (Pubitemid 29075290)
11. A. Zisman, A.J. Pantuck, and D. Chao Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcome J Urol 166 2001 54 58
12. V. Ficarra, F. Guille, and L. Schips Proposal for revision of the TNM classification system for renal cell carcinoma Cancer 104 2005 2116 2123
13. T. Klatte, J.J. Patard, and R.H. Goel Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience J Urol 178 2007 35 40 discussion 40
14. P.I. Karakiewicz, D.J. Lewinshtein, and F.K.-H. Chun Tumor size improves the accuracy of TNM predictions in patients with renal cancer Eur Urol 50 2006 521 529
15. H. Moch, W. Artibani, and B. Delahunt Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma Eur Urol 56 2009 636 643
16. B. Delahunt, J.M. Kittelson, M.R. McCredie, A.E. Reeve, J.H. Stewart, and A.M. Bilous Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters Cancer 94 2001 658 664